glucose, (beta-d)-isomer has been researched along with Neurodegenerative Diseases in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 7 (53.85) | 24.3611 |
| 2020's | 3 (23.08) | 2.80 |
| Authors | Studies |
|---|---|
| Abdian, S; Akkol, EK; Fakhri, S; Farzaei, MH; Gravandi, MM; Sobarzo-Sánchez, E | 1 |
| Elyasi, L; Jahanshahi, M; Jesmi, F; Rosenholm, JM | 1 |
| Gollapalli, BP; Gorantala, J; Magani, SKJ; Mupparthi, SD; Shukla, D; Tantravahi, S; Tiwari, AK; Yarla, NS | 1 |
| Chen, Y; Feng, Z; Jin, H; Lou, Y; Tang, Q; Tian, N; Wang, C; Wang, Q; Wu, Y; Xu, H; Xu, J; Zhang, X; Zhou, Y | 1 |
| Li, JJ; Ling, EA; Liu, SJ; Liu, XY | 1 |
| Gui, Y; Guo, J; Li, F; Li, JH; Li, JJ; Li, XH; Liu, SJ; Liu, XY; Wu, CY; Yang, L; Yuan, Y | 1 |
| Huang, J; Sun, C; Wang, M; Wu, B; Xian, H; Yang, Y; Zhao, J; Zheng, Y | 1 |
| Barhwal, K; Das, SK; Hota, SK; Kumar, A; Srivastava, RB | 1 |
| Baral, S; Kim, J; Lee, HS; Pariyar, R; Seo, J | 1 |
| Hu, Y; Liu, Q; Liu, S; Wang, Z; Xia, Z; Zhang, R | 1 |
| Bidet, M; Joubert, O; Lacombe, B; Mus-Veteau, I; Nehmé, R; Polidori, A; Pucci, B | 1 |
| Miller, G | 1 |
| An, LJ; Chen, J; Duan, YL; Jiang, B; Jiang, L; Tian, YY | 1 |
4 review(s) available for glucose, (beta-d)-isomer and Neurodegenerative Diseases
| Article | Year |
|---|---|
The Neuroprotective Role of Polydatin: Neuropharmacological Mechanisms, Molecular Targets, Therapeutic Potentials, and Clinical Perspective.
Topics: Animals; Cognition Disorders; Drug Delivery Systems; Glucosides; Humans; Neurodegenerative Diseases; Neuroprotective Agents; Spinal Cord Injuries; Stilbenes; Stroke | 2021 |
The Antioxidative Effects of Picein and Its Neuroprotective Potential: A Review of the Literature.
Topics: alpha-Synuclein; Animals; Antioxidants; Curcumin; Glucosides; Neurodegenerative Diseases; Neuroprotective Agents; Panax; Resveratrol; tau Proteins; Withania | 2022 |
Salidroside - Can it be a Multifunctional Drug?
Topics: Animals; Antineoplastic Agents; Diabetes Mellitus; Glucosides; Humans; Hypoglycemic Agents; Hypoxia; Metabolic Diseases; Neoplasms; Neurodegenerative Diseases; Neuroprotective Agents; Phenols; Rhodiola; Wounds and Injuries | 2020 |
Herbal Compounds with Special Reference to Gastrodin as Potential Therapeutic Agents for Microglia Mediated Neuroinflammation.
Topics: Apigenin; Benzyl Alcohols; Glucosides; Glucuronates; Humans; Inflammation; Isoflavones; Microglia; Neurodegenerative Diseases; Neuroprotective Agents; Plants, Medicinal; Renin-Angiotensin System | 2018 |
9 other study(ies) available for glucose, (beta-d)-isomer and Neurodegenerative Diseases
| Article | Year |
|---|---|
Endoplasmic Reticulum Stress and NF-[Formula: see text]B Pathway in Salidroside Mediated Neuroprotection: Potential of Salidroside in Neurodegenerative Diseases.
Topics: Animals; Anti-Inflammatory Agents; Cells, Cultured; Cyclooxygenase 2; Dinoprostone; Endoplasmic Reticulum Stress; Glucosides; Inflammation Mediators; Mice; Microglia; Neurodegenerative Diseases; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Phenols; Phytotherapy; RNA, Messenger; Signal Transduction | 2017 |
Gastrodin attenuates microglia activation through renin-angiotensin system and Sirtuin3 pathway.
Topics: Animals; Benzyl Alcohols; Glucosides; Inflammation Mediators; Lipopolysaccharides; Microglia; NADPH Oxidases; Neurodegenerative Diseases; Rats, Sprague-Dawley; Renin-Angiotensin System; Sirtuin 3 | 2018 |
MADP, a salidroside analog, protects hippocampal neurons from glutamate induced apoptosis.
Topics: Acetylglucosamine; Animals; Apoptosis; bcl-2-Associated X Protein; Cell Survival; Cells, Cultured; Flow Cytometry; Glucosides; Glutamic Acid; Hippocampus; In Situ Nick-End Labeling; Mitogen-Activated Protein Kinases; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Phenols; Phosphorylation; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Signal Transduction | 2014 |
Insulin receptor A and Sirtuin 1 synergistically improve learning and spatial memory following chronic salidroside treatment during hypoxia.
Topics: AMP-Activated Protein Kinases; Animals; Blood-Brain Barrier; Cell Survival; Cyclic AMP Response Element-Binding Protein; DNA, Mitochondrial; Glucosides; Hippocampus; Hypoxia; Male; Maze Learning; Mitochondria; Neurodegenerative Diseases; Phenols; Phosphorylation; Rats; Rats, Sprague-Dawley; Receptor, Insulin; Sirtuin 1; Spatial Memory | 2015 |
Quercetin-3-O-glucuronide promotes the proliferation and migration of neural stem cells.
Topics: Administration, Oral; Animals; Brain-Derived Neurotrophic Factor; Cell Movement; Cell Proliferation; Cells, Cultured; Doublecortin Protein; Flavonoids; Glucosides; Humans; Male; Mice, Inbred ICR; Neural Stem Cells; Neurodegenerative Diseases; Neurogenesis; Neuroprotective Agents; Oncogene Protein v-akt; Phosphorylation; Quercetin; Signal Transduction | 2017 |
Catalpol ameliorates beta amyloid-induced degeneration of cholinergic neurons by elevating brain-derived neurotrophic factors.
Topics: Amyloid beta-Peptides; Animals; Brain; Brain-Derived Neurotrophic Factor; Cells, Cultured; Choline O-Acetyltransferase; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Glucosides; Iridoid Glucosides; Iridoids; Learning; Memory; Mice; Mice, Inbred ICR; Neurites; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, Muscarinic | 2009 |
Stability study of the human G-protein coupled receptor, Smoothened.
Topics: Amino Acid Substitution; Glucosides; Hedgehog Proteins; Humans; Mutation, Missense; Neoplasms; Neurodegenerative Diseases; Protein Stability; Receptors, G-Protein-Coupled; Recombinant Proteins; Saccharomyces cerevisiae; Smoothened Receptor; Surface Plasmon Resonance; Surface-Active Agents; Veratrum Alkaloids | 2010 |
Neurodegenerative disease. From cycad flour, a new suspect emerges.
Topics: Amyotrophic Lateral Sclerosis; Animals; Cycadopsida; Flour; Glucosides; Guam; Humans; Mice; Neurodegenerative Diseases; Parkinsonian Disorders; Sterols | 2006 |
Catalpol protects dopaminergic neurons from LPS-induced neurotoxicity in mesencephalic neuron-glia cultures.
Topics: Animals; Cells, Cultured; Coculture Techniques; Dopamine; Dose-Response Relationship, Drug; Gene Expression Regulation, Enzymologic; Glucosides; Inflammation; Iridoid Glucosides; Iridoids; Lipopolysaccharides; Mesencephalon; Mice; Nerve Degeneration; Neurodegenerative Diseases; Neuroglia; Neurons; Neuroprotective Agents; Nitric Oxide; Nitric Oxide Synthase Type II; Reactive Oxygen Species; Tumor Necrosis Factor-alpha | 2006 |